Status:
UNKNOWN
Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Ministry of Health & Welfare, Korea
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
Brief Summary
The objective of this study is to present evidence-based medicine for development of clinical practice guideline through prospective study of Alzheimer's disease(AD) and mild cognitive impairment(MCI)...
Detailed Description
The specific aims of this study is (1) construction \& maintenance of cohort for Alzheimer's disease(AD) and mild cognitive impairment(MCI); (2) study of epidemiology, rate of progression, risk factor...
Eligibility Criteria
Inclusion
- Alzheimer's disease(AD) and mild cognitive impairment(MCI)will be enrolled in the study.
- the diagnostic criteria of Alzheimer's disease(AD) according to DSM IV or NINCDS -ADRDA
- the diagnostic criteria of mild cognitive impairment(MCI) A. Memory or other cognitive complaint preferably corroborated by an informant B. Objective memory impairment or other cognitive for age and education C. Largely intact general cognitive function D. Essentially preserved ADL E. Not demented
Exclusion
- Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2015
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT01198093
Start Date
November 1 2005
End Date
August 1 2015
Last Update
September 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Kangnam-Ku, South Korea, 135-710